Coastal Investment Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History

Coastal Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$71.37 - $96.85 $12,347 - $16,755	-173 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$64.27 - $86.37 $8,355 - $11,228	130 Added 302.33%	173 $14,000
Q3 2019 Oct 18, 2019	SELL	$67.4 - $85.11 $3,370 - $4,255	-50 Reduced 53.76%	43 $4,000
Q2 2019 Aug 01, 2019	BUY	$80.35 - $93.9 $3,214 - $3,756	40 Added 75.47%	93 $8,000
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $4,462 - $5,226	53 New	53 $5,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.